Leukocyte Surface Biomarkers for Clinical Diagnosis of Sporadic Alzheimer’s Disease

Abe Durrant, Ben J Gu, Samuel P Dickson, Jessie Nicodemus‐Johnson, Garrett B Duncan, Suzanne B Hendrix · 2025

Read Leukocyte Surface Biomarkers for Clinical Diagnosis of Sporadic Alzheimer’s Disease by Abe Durrant, Ben J Gu, Samuel P Dickson, Jessie Nicodemus‐Johnson, Garrett B Duncan, Suzanne B Hendrix (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712590.txt.

Description

Abe Durrant and co-authors hunt for a blood test that spots Alzheimer's disease before symptoms appear. Their 2025 study uses two hundred volunteers from an Australian lifestyle and imaging cohort. Amyloid buildup starts decades before memory fails, and new treatments may work best in that silent window, but brain scans are too costly for routine screening.

The team measured thirty-four surface markers on white blood cells. Twelve markers differed between symptom-free people with and without brain amyloid. Combined, they predicted amyloid status with accuracy scores up to 0.94 in sample and 0.90 in fresh data. Four markers stood out as especially strong. The authors present the panel as a cheap screening candidate.

Catalog record

CREATORAbe Durrant, Ben J Gu, Samuel P Dickson, Jessie Nicodemus‐Johnson, Garrett B Duncan, Suzanne B Hendrix
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11712590

Browse the full library · About the Tower of Babel